PHARMAGREEN BIOTECH INC. Proceeds from Convertible Debt
PHARMAGREEN BIOTECH INC. reported Proceeds from Convertible Debt of $50.00 thousand for the 9-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2023-08-14
- PHARMAGREEN BIOTECH INC. proceeds from convertible debt for the quarter ending 2023-06-30 was $0.00.
- PHARMAGREEN BIOTECH INC. proceeds from convertible debt for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- PHARMAGREEN BIOTECH INC. proceeds from convertible debt for the quarter ending 2022-12-31 was $50.00K.
- PHARMAGREEN BIOTECH INC. proceeds from convertible debt for the quarter ending 2022-06-30 was $0.00.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month |
|---|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | $0.00 derived: sum of 2 quarters · filed 2023-08-14 | $50.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-19 | $50.00K 10-Q · filed 2023-05-19 | |
| 2022-12-31 | $50.00K 10-Q · filed 2023-02-14 | ||
| 2022-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | $30.00K derived: sum of 2 quarters · filed 2023-08-14 | $30.00K 10-Q · filed 2023-08-14 |
| 2022-03-31 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-19 | $30.00K 10-Q · filed 2023-05-19 | |
| 2021-12-31 | $0.00 10-Q · filed 2023-02-14 |